Hofmann T, Schmitt B, Mack B, Lang S, Gires O, Zeidler R (2004)
New Target Genes for Tumor-derived Soluble Factors in Primary Monocytes.
Cancer genomics & proteomics, Issue 2, Vol. 1, 167-176
PubMed: 31394681

Münz M, Hofmann T, Scheibe B, Gänge M, Junghanns KT, Zeidler R, Gires O (2004)
The Carcinoma-associated Antigen EpCAM Induces Glyoxalase 1 Resulting in Enhanced Methylglyoxal Turnover.
Cancer genomics & proteomics, Issue 3, Vol. 1, 241-248
PubMed: 31394659

Rauch J, Ahlemann M, Schaffrik M, Mack B, Ertongur S, Andratschke M, Zeidler R, Lang S, Gires O (2004)
Allogenic antibody-mediated identification of head and neck cancer antigens.
Biochemical and biophysical research communications, Issue 1, Vol. 323, 156-62
DOI: 10.1016/j.bbrc.2004.08.071, PubMed: 15351715

Münz M, Kieu C, Mack B, Schmitt B, Zeidler R, Gires O (2004)
The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation.
Oncogene, Issue 34, Vol. 23, 5748-58
DOI: 10.1038/sj.onc.1207610, PubMed: 15195135

Walz A, Mack B, Schmitt B, Gires O, Wollenberg B, Zeidler R (2004)
Antitumour effects of a bispecific trivalent antibody in multicellular tumour spheroids.
Anticancer research, Issue 2B, Vol. 24, 887-93
PubMed: 15161042

Schlee M, Krug T, Gires O, Zeidler R, Hammerschmidt W, Mailhammer R, Laux G, Sauer G, Lovric J, Bornkamm GW (2004)
Identification of Epstein-Barr virus (EBV) nuclear antigen 2 (EBNA2) target proteins by proteome analysis: activation of EBNA2 in conditionally immortalized B cells reflects early events after infection of primary B cells by EBV.
Journal of virology, Issue 8, Vol. 78, 3941-52
DOI: 10.1128/jvi.78.8.3941-3952.2004, PubMed: 15047810